ML290, an Allosteric Relaxin-RXFP1 Agonist, Attenuates Experimental Pulmonary Hypertension Meeting Abstract

Yang, P., Yung, L., van Deusen, C. et al. (2018). ML290, an Allosteric Relaxin-RXFP1 Agonist, Attenuates Experimental Pulmonary Hypertension . AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197



Industry Collaboration International Collaboration

cited authors

  • Yang, P.; Yung, L.; van Deusen, C.; Bocobo, G.; Dinter, T.; Cavallo, J.; Chain, D.; Dwyer, S. C.; Southwood, M.; Jia, Z.; Morrell, N. W.; Illiano, S.; Ferrer, M.; Southall, N.; Wilson, K. J.; Marugan, J. J.; Agoulnik, A. I.; Yu, P. B.

fiu authors

publication date

  • January 1, 2018

webpage

published in

category

volume

  • 197